Clinical Trial Update: A Pilot Study Using Placenta Derived Decidual Stromal Cells for Toxicity and Inflammation With Special Focus to the Allogeneic Hematopoietic Cell Transplantation Setting [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 pilot study evaluating placenta-derived decidual stromal cells to reduce toxicity and inflammation in the allogeneic hematopoietic cell transplantat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Injury

Drugs mentioned

• Placenta-Derived Decidual Stromal Cells (decidual stromal cells)

Snippet

Sponsor: Karolinska Institutet | Conditions: Acute Lung Injury, Decidual Stromal Cells | Phase 1, Phase 2 | Status: UNKNOWN